The coumermycins: developments in the late 1970s.
D049933:Aminocoumarins; D000818:Animals; D055598:Chemical Phenomena; D002621:Chemistry; D003374:Coumarins / Q000096:biosynthesis / Q000494:pharmacology*; D004260:DNA Repair / Q000187:drug effects; D004261:DNA Replication / Q000187:drug effects*; D004250:DNA Topoisomerases, Type II / Q000235:genetics; D004926:Escherichia coli / Q000201:enzymology; D008930:Mitochondria, Liver / Q000201:enzymology; D008954:Models, Biological; D009675:Novobiocin / Q000494:pharmacology; D011758:Pyrroles / Q000096:biosynthesis / Q000494:pharmacology; D051381:Rats; D059005:Topoisomerase II Inhibitors; D014158:Transcription, Genetic / Q000187:drug effects
D049933:Aminocoumarins; D003374:Coumarins; D011758:Pyrroles; D059005:Topoisomerase II Inhibitors; D009675:Novobiocin; D004250:DNA Topoisomerases, Type II; C004628:coumermycin